Journal of Dermatological Treatment (Dec 2023)
Tralokinumab rapidly improves subjective symptoms and quality of life in patients with moderate-to-severe atopic dermatitis: a real-life 16-week experience
Abstract
No abstracts available.
Journal of Dermatological Treatment (Dec 2023)